Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-090917
Filing Date
2023-08-14
Accepted
2023-08-14 07:45:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2323647d2_sc14d9c.htm SC14D9C 6954
  Complete submission text file 0001104659-23-090917.txt   8767
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88971 | Film No.: 231166321
SIC: 2834 Pharmaceutical Preparations